HIF1A and myocardial infarction: In rodent and porcine models of limb ischemia and myocardial infarction, gene therapy vectors of constitutively active HIF-1α (e.g., AdCA5) and small-molecule PHD inhibitors (e.g., DMOG, Roxadustat) improved capillary density, blood flow, and functional recovery [144].